Myostatin: a potential therapeutic target for metabolic syndrome

The signaling pathway of MSTN. The binding of MSTN to ActRIIA and ActRIIB requires the involvement of activin-like kinase (ALK) 4/5, which subsequently leads to the phosphorylation of the downstream Smad2/3 complex, which in turn recruits Smad4. Meanwhile, phosphorylated Smad2/3 also inhibited AKT activation and promoted the dephosphorylated of FOXO. The Smad complex and dephosphorylated FOXO can enter the nucleus and act as transcription factors to regulate the expression of MuRF1 and Atrogin1 muscle atrophy-related proteins.
Myostatin: a potential therapeutic target for metabolic syndrome

Publication

Myostatin: a potential therapeutic target for metabolic syndrome. (2023) Ming Yang, et al. Front Endocrinol (Lausanne). 2023;14:1181913. Figure: F1.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates ActRIIA/B ACTRIIB ncbigene_synonym ACVR2B 93
Homo sapiens Primates Smad2 SMAD2 ncbigene_symbol SMAD2 4087
Homo sapiens Primates Smad2/3 SMAD3 ncbigene_symbol SMAD3 4088
Homo sapiens Primates MSTN MSTN ncbigene_symbol MSTN 2660
Homo sapiens Primates Smad2/3/4 SMAD4 ncbigene_symbol SMAD4 4089
Homo sapiens Primates ALK4 ALK4 ncbigene_synonym ACVR1B 91
Homo sapiens Primates ALK4/5 ALK5 ncbigene_synonym TGFBR1 7046
Homo sapiens Primates FOXO FOXO famplex_relations FOXO1 2308
Homo sapiens Primates FOXO FOXO famplex_relations FOXO3 2309
Homo sapiens Primates FOXO FOXO famplex_relations FOXO4 4303
Homo sapiens Primates FOXO FOXO famplex_relations FOXO6 100132074
Homo sapiens Primates AKT AKT ncbigene_synonym AKT1 207
Homo sapiens Primates AKT AKT famplex_relations AKT2 208
Homo sapiens Primates AKT AKT famplex_relations AKT3 10000
Homo sapiens Primates MuRF1 MURF1 ncbigene_synonym TRIM63 84676

Chemical mentions

Word Match MeSH Name ChEBI

Disease mentions

Word Match MeSH Name DOID